Tax-loss harvesting alternatives for PRGO

Among the 30 Pharmaceuticals peers screened, SUPN (Supernus Pharmaceuticals, Inc.) has tracked PRGO most closely over the past year, with a return correlation of 0.46. The strongest fund stand-in is XHE (SPDR S&P Health Care Equipment) at 0.35 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →

STOCKS

Single-name peers

Ticker	Name	Sub-industry	1Y	3Y	5Y	10Y
SUPN	Supernus Pharmaceuticals, Inc.	Pharmaceuticals	0.46	0.24	0.25	0.24
ELAN	Elanco	Pharmaceuticals	0.36	0.29	0.29	0.31
PBH	Prestige Consumer Healthcare	Pharmaceuticals	0.34	0.31	0.28	0.29
ZTS	Zoetis Inc.	Pharmaceuticals	0.28	0.24	0.26	0.27
SNY	Sanofi S.A.	Pharmaceuticals	0.27	0.24	0.22	0.26
AZN	AstraZeneca	Pharmaceuticals	0.26	0.23	0.22	0.22
AMPH	Amphstar Pharmaceuticals, Inc.	Pharmaceuticals	0.25	0.21	0.21	0.24
PFE	Pfizer Inc.	Pharmaceuticals	0.22	0.26	0.21	0.28
VTRS	Viatris	Pharmaceuticals	0.22	0.28	0.29	0.38
MRK	Merck & Co.	Pharmaceuticals	0.22	0.22	0.21	0.25
COLL	Collegium Pharmaceutical, Inc.	Pharmaceuticals	0.21	0.19	0.20	0.24
GSK	GSK plc	Pharmaceuticals	0.21	0.18	0.18	0.23
PAHC	Phibro Animal Health	Pharmaceuticals	0.21	0.22	0.23	0.24
ANIP	ANI Pharmaceuticals, Inc.	Pharmaceuticals	0.21	0.24	0.20	0.28
ACAD	Acadia Pharmaceuticals	Pharmaceuticals	0.20	0.21	0.19	0.20
AMRX	Amneal Pharmaceuticals	Pharmaceuticals	0.19	0.23	0.21	0.25
LLY	Eli Lilly	Pharmaceuticals	0.18	0.16	0.18	0.22
INDV	Indivior	Pharmaceuticals	0.17	0.13	-0.01	0.00
NVO	Novo Nordisk	Pharmaceuticals	0.16	0.15	0.17	0.20
ALKS	Alkermes plc	Pharmaceuticals	0.14	0.21	0.20	0.25
JNJ	Johnson & Johnson	Pharmaceuticals	0.13	0.19	0.19	0.28
OGN	Organon & Co.	Pharmaceuticals	0.11	0.19	0.22	—
ABBV	AbbVie Inc.	Pharmaceuticals	0.10	0.15	0.15	0.22
BMY	Bristol-Myers Squibb	Pharmaceuticals	0.09	0.20	0.19	0.25
JAZZ	Jazz Pharmaceuticals	Pharmaceuticals	0.07	0.17	0.19	0.27
INVA	Innoviva, Inc.	Pharmaceuticals	0.06	0.15	0.16	0.21
LQDA	Liquidia Corporation	Pharmaceuticals	0.04	0.08	0.09	0.10
PTCT	PTC Therapeutics, Inc.	Pharmaceuticals	0.02	0.18	0.17	0.15
CORT	Corcept Therapeutics Incorporated	Pharmaceuticals	0.01	0.05	0.07	0.12
PCRX	Pacira BioSciences, Inc.	Pharmaceuticals	-0.03	0.07	0.11	0.19

ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

Ticker	Name	Focus	Match	1Y	3Y	5Y	10Y
XHE	SPDR S&P Health Care Equipment	Medical Devices (Equal Wt)	SUB-IND	0.35	0.36	0.35	0.36
FHLC	Fidelity MSCI Health Care ETF	Health Care Sector	SECTOR	0.34	0.37	0.36	0.42
IHI	iShares Medical Devices ETF	Medical Devices	SUB-IND	0.34	0.32	0.33	0.35
IYH	iShares US Healthcare ETF	Health Care Sector	SECTOR	0.34	0.36	0.35	0.41
VHT	Vanguard Health Care ETF	Health Care Sector	SECTOR	0.33	0.36	0.36	0.41
XLV	Health Care Select Sector SPDR	Health Care Sector	SECTOR	0.33	0.35	0.35	0.41
XPH	SPDR S&P Pharmaceuticals	Pharmaceuticals (Equal Wt)	INDUSTRY	0.30	0.37	0.38	0.48
PPH	VanEck Pharma ETF	Pharmaceuticals	INDUSTRY	0.29	0.33	0.35	0.47
IHE	iShares US Pharmaceuticals ETF	Pharmaceuticals	INDUSTRY	0.29	0.35	0.36	0.46
IBB	iShares Biotechnology ETF	Biotechnology	INDUSTRY	0.25	0.32	0.30	0.37
IHF	iShares Health Care Providers	Health Care Providers	INDUSTRY	0.21	0.23	0.25	0.33
XBI	SPDR S&P Biotech ETF	Biotechnology (Equal Wt)	INDUSTRY	0.19	0.27	0.26	0.32

NEXT STEPS

Harvesting a loss in PRGO?

Estimate what the harvest could save →Check the eight wash-sale traps →Document the trade with a Tax Memo →

Replacement research for PRGO's peers

SUPN ELAN PBH ZTS SNY AZN AMPH PFE VTRS MRK COLL GSK PAHC ANIP ACAD AMRX LLY INDV NVO ALKS JNJ OGN ABBV BMY JAZZ INVA LQDA PTCT CORT PCRX

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.